Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Nuwellis, Inc.

NASDAQ: NUWE · Industrial Applications and Services · 4 alerts · CIK 1506492

Share price
$4.48Close, Nov 16
Market cap
$2.42M
Shares outstanding
540.91KLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic ApparatusSIC 3845

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nuwellis, Inc. filings on SEC EDGAR ↗

8:36 AM ET 8-K
Investor Presentation

Nuwellis Investor Presentation

Nuwellis, Inc. filed an updated corporate investor presentation dated November 17, 2026, to be used for upcoming investor communications and conferences. The presentation highlights the company's Aquadex ultrafiltration technology, its $4.4 billion U.S. market opportunity, and year-to-date revenue growth of 13%.

4:07 PM ET 10-Q
Financial Results

Nuwellis Q3 2026 Results: Net Loss of $1.97M

Nuwellis, Inc. reported net sales of $6.58 million for the nine months ended September 30, 2026, a 12.6% increase over the prior year. Despite improved gross margins, the company incurred a net loss of $11.34 million, driven by higher operating expenses and significant financing-related costs, though this was an improvement from the $15.10 million loss in the same period of 2025.

Key figure
Net loss $1.97M
4:03 PM ET 8-K
Financial Results

Nuwellis Financial Results

Nuwellis reported Q3 2026 financial results with net sales of $2.2 million and a 24% improvement in operating loss to $2.1 million. The company highlighted significant gross margin expansion to 69.5% and an 88% year-to-date increase in Aquadex console unit sales, which builds the installed base for future recurring revenue.

Term
Q3 2026

“We have made meaningful progress in strengthening Nuwellis both commercially and financially. Year to date, console unit sales have nearly doubled, expanding our installed base and creating a larger opportunity to grow recurring circuit revenue. Although our third quarter faced a tough comparison against the prior-year period when we fulfilled a significant backorder, the underlying momentum in our business remains strong, as evidenced by the growth in our pediatric segment.”

Mike McCormick, Nuwellis President and Chief Executive
9:19 AM ET 8-K
Reverse Stock Split

Nuwellis Reverse Stock Split

Nuwellis, Inc. has announced a 1-for-9 reverse stock split of its issued and outstanding common stock, effective October 26, 2026. The split-adjusted shares will begin trading on the Nasdaq Capital Market under the existing symbol 'NUWE' on October 27, 2026. This action consolidates every nine shares into one share to adjust the company's capital structure.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.